Aurobindo Pharma reports strong Q1 numbers; consolidated net profit surges 61%

12 Aug 2024 Evaluate

Aurobindo Pharma has reported results for first quarter ended June 30, 2024 (Q1FY25). 

The company has reported 2.15% fall in its net profit at Rs 329.04 crore for Q1FY25 as compared to Rs 336.27 crore for the same quarter in the previous year. However, total income of the company increased by 1.58% at Rs 2,525.41 crore for Q1FY25 as compared to Rs 2,486.16 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 61.17% rise in its net profit at Rs 918.22 crore for the quarter ended June 30, 2024 as compared to Rs 569.71 crore for the same quarter in the previous year. Total income of the company increased by 11.79% at Rs 7,787.95 crore for Q1FY25 as compared to Rs 6,966.85 crore for the corresponding quarter previous year.


Aurobindo Pharma Share Price

1240.70 -14.70 (-1.17%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.